Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H39N.C2H4O2 |
| Molecular Weight | 329.5609 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)=O.CCCCCCCCCCCCCCCCCCN
InChI
InChIKey=UPHWVVKYDQHTCF-UHFFFAOYSA-N
InChI=1S/C18H39N.C2H4O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19;1-2(3)4/h2-19H2,1H3;1H3,(H,3,4)
| Molecular Formula | C2H4O2 |
| Molecular Weight | 60.052 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C18H39N |
| Molecular Weight | 269.509 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Stearamine is an aliphatic amine intended for use in cosmetic formulations as antistatic agent. In cosmetics and personal care products, Lauramine and Stearamine have been used in hair preparations. Stearamine is also used as a corrosion-inhibiting boiler-water additive. Stearamine has antimicrobial properties. Stearylamine has been shown to prevent drug (lansoprazole) degradation and maintained drug stable in nanostructured lipid carriers (NLCs). Stearamine is used as positive charge inducing agent in different pharmaceutical formulations. Thus, the presence of stearylamine reduced the permeability coefficient for the cationic species of the drugs by approximately an order of magnitude, but had no effect on the neutral species of the drugs. The efflux curves observed for both verapamil and prochlorperazine could be mathematically modeled by assuming that the primary influence of stearylamine was on the development of a positive surface charge density on the inner monolayer of the liposome. Taken in sum, these results indicate that stearylamine is effective at decreasing the leakage of cationic drugs from liposomes, and may prove to be a valuable component of liposomal drug formulations.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. | 2005-10-15 |
|
| Electronic properties of single-walled carbon nanotube networks. | 2005-04-27 |
|
| Structural properties and Raman spectroscopy of lipid Langmuir monolayers at the air-water interface. | 2005-04-25 |
|
| Evidence for the role of organic layers in photoconductivity of organic/inorganic hybrid nanosheets as prepared by Langmuir-Blodgett methods. | 2005-04-21 |
|
| Synthesis of functional microcapsules containing suspensions responsive to electric fields. | 2005-04-15 |
|
| Effect of the intercalation conditions of a montmorillonite with octadecylamine. | 2005-04-01 |
|
| Development of simple thiol-reactive liposome formulations, one-step analysis and physicochemical characterization. | 2005-04 |
|
| Keggin ion mediated synthesis of hydrophobized Pd nanoparticles for multifunctional catalysis. | 2005-03-15 |
|
| Swelling behavior of organoclays in styrene and exfoliation in nanocomposites. | 2005-03-15 |
|
| Treatment of focal cerebral ischemia with liposomal nerve growth factor. | 2005-03-04 |
|
| Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. | 2005-03-02 |
|
| Physicochemical characterization and gene transfection efficiency of lipid emulsions with various co-emulsifiers. | 2005-01-31 |
|
| High-throughput mass spectrometer using atmospheric pressure ionization and a cylindrical ion trap array. | 2005-01-15 |
|
| Time-resolved fluorescence spectroscopic and scanning near-field optical microscopic studies of rhodamine dye adsorbed in cationic Langmuir-Blodgett films. | 2005-01-01 |
|
| Interactions of lipid monolayers with the natural biopolymer hyaluronic acid. | 2004-12-15 |
|
| Preparation of microcapsules containing two-phase core materials. | 2004-12-07 |
|
| Immobilization of Candida bombicola cells on free-standing organic-gold nanoparticle membranes and their use as enzyme sources in biotransformations. | 2004-12-04 |
|
| Development of a topical niosomal preparation of acetazolamide: preparation and evaluation. | 2004-12 |
|
| Kinetic studies of cholesterol oxidation as inhibited by stearylamine during heating. | 2004-11-17 |
|
| Determination of aliphatic amines in mineral flotation liquors and reagents by high-performance liquid chromatography after derivatization with 4-chloro-7-nitrobenzofurazan. | 2004-11-05 |
|
| Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. | 2004-11-05 |
|
| Development of liposomal amphotericin B dry powder inhaler formulation. | 2004-09-17 |
|
| Time-resolved total internal reflection fluorescence study on hybridization of complementary single-stranded DNAs at a water/oil interface. | 2004-09-01 |
|
| On the mechanism of the hofmeister effect. | 2004-09-01 |
|
| Structure analysis of intercalated layer silicates: combination of molecular simulations and experiment. | 2004-09-01 |
|
| A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release. | 2004-09 |
|
| Synthesis of aqueous Au core-Ag shell nanoparticles using tyrosine as a pH-dependent reducing agent and assembling phase-transferred silver nanoparticles at the air-water interface. | 2004-08-31 |
|
| Synthesis and isolation of cobalt hexacyanoferrate/chromate metal coordination nanopolymers stabilized by alkylamino ligand with metal elemental control. | 2004-08-11 |
|
| Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance. | 2004-08-09 |
|
| Effect of salt on the hybridization of DNA by sequential immobilization of oligonucleotides at the air-water interface in the presence of ODA/DOTAP monolayers. | 2004-08-01 |
|
| Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. | 2004-07-16 |
|
| Influence of ammonium nitrate in phase transitions of Langmuir and Langmuir-Blodgett films at air/solution and solid/solution interfaces. | 2004-07-01 |
|
| Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery. | 2004-06-18 |
|
| Characterization of amphotericin B liposome formulations. | 2004-05 |
|
| Relaxation behaviors of monolayers of octadecylamine and stearic acid at the air/water interface. | 2004-04-13 |
|
| Sphingolipids as bioactive regulators of thrombin generation. | 2004-03-26 |
|
| Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. | 2004-03-24 |
|
| Mineralization mechanism of calcium phosphates under three kinds of Langmuir monolayers. | 2004-03-16 |
|
| Synthesis and evaluation of a hematoporphyrin derivative in a folate receptor-targeted solid-lipid nanoparticle formulation. | 2004-03-16 |
|
| Formulation and evaluation of oil-in-water emulsions of piperine in visceral leishmaniasis. | 2004-03 |
|
| Stability and transdermal absorption of topical amphotericin B liposome formulations. | 2004-02-11 |
|
| Invertase-lipid biocomposite films: preparation, characterization, and enzymatic activity. | 2004-02-07 |
|
| Tunneling characteristics of octadecyl derivatives on tin and indium electrodes. | 2004-02-03 |
|
| Molecular transfer and transport in noncovalent microcontact printing. | 2004-02-03 |
|
| Time-dependent complexation of glucose-reduced gold nanoparticles with octadecylamine Langmuir monolayers. | 2004-02-01 |
|
| Cationic stearylamine-containing biodegradable microparticles for DNA delivery. | 2004-02 |
|
| [DNA complexes, formed on aqueous phase surfaces: new planar polymeric and composite nanostructures]. | 2004-01-13 |
|
| The covalent coupling of HAV-VP3 (110-121) synthetic peptide to liposomes: physicochemical studies. | 2004-01-09 |
|
| Stability of desmopressin loaded in liposomes. | 2003-11 |
|
| The effect of small cations on the positive electrospray responses of proteins at low pH. | 2003-10-15 |
Patents
Sample Use Guides
In a subchronic feeding study in rats, 3,000 ppm of Stearamine in the diet caused weight loss and increased mortality, with an accumulation of his- tiocytes in the mucosa of the small intestine and mesenteric lymph nodes. A diet of 500 ppm did not produce these effects. Dogs fed Stearamine at 15 mg/kg/day showed the same histiocyte accumulation. In a 2-year chronic feed- ing study in rats, Stearamine at concentrations up to 500 ppm (maximum tested) showed no significant increase in the incidence of tumors.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:00:23 GMT 2025
by
admin
on
Mon Mar 31 22:00:23 GMT 2025
|
| Record UNII |
856J14021A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
218-583-7
Created by
admin on Mon Mar 31 22:00:23 GMT 2025 , Edited by admin on Mon Mar 31 22:00:23 GMT 2025
|
PRIMARY | |||
|
856J14021A
Created by
admin on Mon Mar 31 22:00:23 GMT 2025 , Edited by admin on Mon Mar 31 22:00:23 GMT 2025
|
PRIMARY | |||
|
16608
Created by
admin on Mon Mar 31 22:00:23 GMT 2025 , Edited by admin on Mon Mar 31 22:00:23 GMT 2025
|
PRIMARY | |||
|
2190-04-7
Created by
admin on Mon Mar 31 22:00:23 GMT 2025 , Edited by admin on Mon Mar 31 22:00:23 GMT 2025
|
PRIMARY | |||
|
DTXSID2051263
Created by
admin on Mon Mar 31 22:00:23 GMT 2025 , Edited by admin on Mon Mar 31 22:00:23 GMT 2025
|
PRIMARY | |||
|
81938
Created by
admin on Mon Mar 31 22:00:23 GMT 2025 , Edited by admin on Mon Mar 31 22:00:23 GMT 2025
|
PRIMARY |